The Board of Directors of PharmaCyte Biotech, Inc. has authorized a buyback plan on January 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.155 USD | -0.99% | +2.13% | -0.23% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.23% | 18.22M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- PMCB Stock
- News PharmaCyte Biotech, Inc.
- PharmaCyte Biotech, Inc. authorizes a Buyback Plan.